Summit Therapeutics
SMMT
S$27.00
Share price
-0.38%
Change (1 day)
144.65%
Change (1 year)
Categories
Summit Therapeutics (SMMT) - Total debt
Total debt on the balance sheet as of March 2025 : S$8.21 Million
According to Summit Therapeutics 's latest financial reports the company's total debt is S$8.21 Million. A company’s total debt is the sum of all current and non-current debts.
Summit Therapeutics - Total debt on balance sheet (from 2018 to 2020)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | S$9.81 M | -93% |
| 2023-12-31 | S$0.14 B | -79.85% |
| 2022-12-31 | S$0.69 B | 18391.12% |
| 2021-12-31 | S$3.76 M | 511.38% |
| 2020-12-31 | S$0.61 M | |
| 2019-01-31 | S$1.77 M | -25.68% |
| 2018-01-31 | S$2.38 M | |
| 2009-01-31 | S$4.08 M | -48.34% |
| 2008-01-31 | S$7.9 M | 101.38% |
| 2007-01-31 | S$3.92 M | 0.65% |
| 2006-01-31 | S$3.9 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | S$1.71 B | 20,733.33% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | S$21.14 M | 157.35% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | S$0.34 B | 4,084.91% | 🇺🇸 USA |